![Gary Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Lee
Teknisk/Vetenskaplig/F&U Direktör på
LYELL IMMUNOPHARMA, INC.
Förmögenhet: 232 270 $ per 2026-08-31
Profil
Gary Lee is currently Chief Scientific Officer at Lyell Immunopharma, Inc. since 2022.
Formerly, Dr. Lee was Vice President-Cell Therapy at Sangamo Therapeutics, Inc. from 2005 to 2018 and Chief Scientific Officer at Senti Sub I, Inc. from 2018 to 2022.
Education includes undergraduate studies at California Institute of Technology and a doctorate from the University of California, Berkeley.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
LYELL IMMUNOPHARMA, INC. 0,07 % | 2026-08-21 | 16 220 ( 0,07 % ) | 232 270 $ | 2026-08-31 |
Aktiva positioner av Gary Lee
| Företag | Position | Start |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2022-01-31 |
Tidigare kända positioner av Gary Lee
| Företag | Position | Slut |
|---|---|---|
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Develops novel therapeutics | Teknisk/Vetenskaplig/F&U Direktör | 2022-01-01 |
| SANGAMO THERAPEUTICS, INC. | Företagsledare/Principal | 2018-10-01 |
Gary Lees utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
63
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Develops novel therapeutics | Health Technology |
Lyell Immunopharma, Inc.
 Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
